George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here.
As was mentioned yesterday it could be easier to recruit patients in the UK because of the NHS and because geographically the cancer centers being used cover the whole of England.
Thanks I found this paper interesting too
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4976787/
Agreed on both fronts RD.
And it's working for some patients where it wasn't expected to work, which is fantastic.
I wonder if any of the 2 week cohort are first line as Chris did say some might be in the last presentation.
Timster, how'd you like that post yesterday calling you out for being a t*at getting so many recs
I cried myself to sleep last night atdb.
Oh by the way the pre|CISION platform works as intended and in the case of ava6000 it's delivering a chemo drug proven over 50 years. What don't you understand?